What is thrombolysis and who qualifies for it? 

Thrombolysis is an emergency medical treatment used to dissolve dangerous blood clots that have formed in the brain blood vessels. Often described as clot busting medication, it involves the intravenous administration of a drug called alteplase or Tenecteplase. These medications work by activating the body natural clot dissolving system, breaking down the fibrin mesh that holds a blockage together. By clearing the obstruction, thrombolysis restores the flow of oxygen and nutrients to the affected brain tissue. Because brain cells die rapidly when deprived of blood, this treatment is a race against time and is one of the most effective ways to reduce long term disability following an ischaemic stroke. 

In a clinical setting, thrombolysis is not suitable for every patient. It is reserved specifically for those experiencing an ischaemic stroke, which accounts for approximately eighty five percent of all stroke cases. Because the medication significantly thins the blood, it carries a risk of causing internal bleeding. Therefore, medical teams must follow a strict set of inclusion and exclusion criteria to ensure the treatment is safe for the individual. The most important factor in determining eligibility is the time that has elapsed since the first stroke symptoms appeared, as the risks of the medication begin to outweigh the benefits as more time passes. 

What we will discuss in this article 

• The biochemical process of how thrombolysis dissolves blood clots 

• The critical four and a half hour time window for treatment 

• Clinical eligibility criteria for receiving clot busting drugs 

• Why a CT scan is a mandatory prerequisite for thrombolysis 

• Common exclusion criteria and safety contraindications 

• Potential risks and side effects of the treatment 

• Emergency guidance for identifying symptoms that qualify for assessment 

How thrombolysis works in the brain 

Thrombolysis is a sophisticated pharmacological intervention that targets the structural integrity of a blood clot. 

Breaking down the blockage 

When a blood clot forms, it is held together by a protein called fibrin. Clot busting drugs are recombinant tissue plasminogen activators rtPA. When injected into the bloodstream, they convert an inactive substance called plasminogen into its active form, plasmin. Plasmin then acts like a pair of chemical scissors, cutting through the fibrin strands. As the mesh dissolves, the clot breaks apart, allowing blood to flow back into the ischaemic penumbra, which is the area of brain tissue that is damaged but not yet dead. 

Restoring oxygenation 

The primary goal of this chemical process is to salvage as much brain tissue as possible. While the core of a stroke may suffer irreversible damage quickly, the surrounding areas can be saved if the blood supply is restored within a specific timeframe. This is why hospital teams prioritize thrombolysis in the hyper acute phase of care. Successful thrombolysis can significantly improve a patient chances of regaining motor skills, speech, and independence in the months following their stroke. 

The critical window and eligibility 

To qualify for thrombolysis, a patient must meet specific clinical requirements that balance the urgency of the stroke against the risks of the drug. 

The time window 

The gold standard for thrombolysis is that it must be administered within four and a half hours of the onset of stroke symptoms. In some very specific cases, this window can be extended, but for the majority of patients, the benefits diminish significantly after this point. This is because the brain tissue becomes more fragile over time, and restoring blood flow too late can actually cause the weakened vessels to burst, leading to a secondary haemorrhagic stroke. 

Mandatory brain imaging 

No patient can receive thrombolysis without first having an emergency brain scan, usually a CT scan. The purpose of this scan is not necessarily to see the clot, but to ensure that there is no bleeding in the brain. If a scan shows a haemorrhagic stroke, thrombolysis is strictly forbidden, as thinning the blood would cause the bleeding to become uncontrollable and likely fatal. A normal CT scan in a patient with clear stroke symptoms is often the green light for the medical team to proceed with the medication. 

Comparison: Eligibility for Thrombolysis 

Factor	Qualifies for Treatment	Does NOT Qualify
Stroke Type	Ischaemic Clot	Haemorrhagic Bleed
Time Onset	Under 4.5 hours	Over 4.5 hours or unknown
Age	Over 18 usually	Varies by clinical case
Blood Pressure	Controlled below 185/110	Persistently high blood pressure
Recent Surgery	No major surgery in 14 days	Recent major internal surgery
Blood Thinners	Not currently taking strong ones	High levels of anticoagulants in blood

Exclusion criteria and safety risks 

Because thrombolysis affects the entire body ability to clot, doctors must screen for anything that might increase the risk of a dangerous bleed. 

• Recent Bleeding: Patients with a history of recent internal bleeding, such as a stomach ulcer or a recent head injury, are generally excluded. 

• Blood Pressure: If a patient blood pressure is extremely high and cannot be lowered safely with medication, thrombolysis is withheld to prevent a brain haemorrhage. 

• Previous Stroke: A very recent stroke or certain types of brain surgery in the preceding months can make the brain tissue too vulnerable for clot busting drugs. 

• Low Blood Sugar: Medical teams always check blood sugar, as hypoglycaemia can mimic stroke symptoms. If the symptoms are caused by sugar levels, thrombolysis is not appropriate. 

To Summarise 

Thrombolysis is a life saving emergency treatment for ischaemic stroke that uses specialized medication to dissolve blood clots and restore brain circulation. To qualify, a patient must arrive at the hospital and receive a brain scan within a strict four and a half hour window from the start of their symptoms. While it is a powerful tool for reducing the long term impact of a stroke, its use is carefully controlled through rigorous eligibility checks to minimize the risk of internal bleeding. When administered quickly to the right patient, thrombolysis is one of the most effective interventions in modern neurology, preserving brain function and improving the path to recovery. 

Emergency guidance 

If you notice any signs of a stroke, call 999 immediately. Use the FAST test: Face is it drooping on one side, Arms can they raise both and keep them there, Speech is it slurred or strange, and Time it is time to call emergency services. Note the exact time the symptoms started and tell the paramedics. This time is the single most important factor in determining whether you or your loved one will qualify for life saving thrombolysis treatment at the hospital. 

Authority Snapshot 

This article was reviewed by Dr. Stefan Petrov, a physician with an MBBS and postgraduate certifications including Basic Life Support BLS, Advanced Cardiac Life Support ACLS, and the Medical Licensing Assessment PLAB 1 and 2. He has hands on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient focused health content and teaching clinical skills to junior doctors within the NHS in 2026.